Morbidity and Mortality Weekly Report: Recommendations and Reports, August 8, 2008 / Vol. 57 / No. RR-7

Details

• Alternative Title:
  Prevention and Control of Influenza : Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008
• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports
• Personal Author:
  Bresee, Joseph S. ; Broder, Karen R. ; Cox, Nancy (Nancy J.) ; Fiore, Anthony E. ; Iskander, John K. ; Mootrey, Gina T. ; Shay, David K. ; Uyeki, Timothy M.
• Corporate Authors:
  United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; Centers for Disease Control and Prevention (U.S.). Immunization Safety Office. ; National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. ; National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.
• Description:
  "This report updates the 2007 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2007;56[No. RR-6]). The 2008 recommendations include new and updated information. Principal updates and changes include 1) a new recommendation that annual vaccination be administered to all children aged 5--18 years, beginning in the 2008--09 influenza season, if feasible, but no later than the 2009--10 influenza season; 2) a recommendation that annual vaccination of all children aged 6 months through 4 years (59 months) continue to be a primary focus of vaccination efforts because these children are at higher risk for influenza complications compared with older children; 3) a new recommendation that either trivalent inactivated influenza vaccine or live, attenuated influenza vaccine (LAIV) be used when vaccinating healthy persons aged 2 through 49 years (the previous recommendation was to administer LAIV to person aged 5--49 years); 4) a recommendation that vaccines containing the 2008--09 trivalent vaccine virus strains A/Brisbane/59/2007 (H1N1)-like, A/Brisbane/10/2007 (H3N2)-like, and B/Florida/4/2006-like antigens be used; and, 5) new information on antiviral resistance among influenza viruses in the United States. Persons for whom vaccination is recommended are listed in boxes 1 and 2. These recommendations also include a summary of safety data for U.S. licensed influenza vaccines. This report and other information are available at CDC's influenza website (http://www.cdc.gov/flu), including any updates or supplements to these recommendations that might be required during the 2008--09 influenza season. Vaccination and health-care providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information." - p. 1
• Subjects:
  Antiviral Agents / Therapeutic Use Disease Outbreaks / Prevention & Control Influenza / Drug Therapy Influenza A Virus Influenza B Virus Influenza Vaccines / Administration & Dosage Mass Vaccination Vaccination / Standards
• Source:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 2008; v. 57, no. 7
• Series:
  Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  1057-5987 (print) ; 1545-8601 (digital)
• Pubmed ID:
  18685555
• Document Type:
  Journal Issue
• Genre:
  Practice Guideline
• Pages in Document:
  64 pdf pages
• Volume:
  57
• Issue:
  7
• Collection(s):
  Guidelines and Recommendations Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:121b9b27424640036256edd4149fde1f1b0df07f255c6c498a7924586bcba58927611d6ec8850b2f8cd9dfd64828ea5ec9680b33230a2cdcfec5189909e7b756
• Download URL:
  https://stacks.cdc.gov/view/cdc/7015/cdc_7015_DS1.pdf
• File Type:
  [PDF - 1.03 MB ]